Syncom Formulations (India) Ltd

About [ edit ]

Syncom Formulations (India) is engaged in manufactures and markets more than 200 pharmaceutical formulations products in various dosage forms like Tablets, Capsules, Liquids Orals, Liquid Vials and Ampoule Injections & Dry Vial injections, Dry Syrups, Ointments, Inhalers and Herbals.

  • Market Cap 665 Cr.
  • Current Price 8.42
  • High / Low 9.48 / 1.35
  • Stock P/E 63.1
  • Book Value 1.49
  • Dividend Yield 0.00 %
  • ROCE 13.3 %
  • ROE 9.32 %
  • Face Value 1.00

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter

Cons

  • Stock is trading at 5.67 times its book value
  • Company has a low return on equity of 9.91% for last 3 years.
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Jun 2012 Sep 2012 Dec 2012 Mar 2013 Jun 2013 Sep 2013 Dec 2013 Mar 2014
26.91 11.35 34.66 34.14 34.81 30.41 37.48 40.65 42.75
26.32 10.63 31.25 30.43 32.01 27.41 33.62 36.02 38.00
Operating Profit 0.59 0.72 3.41 3.71 2.80 3.00 3.86 4.63 4.75
OPM % 2.19% 6.34% 9.84% 10.87% 8.04% 9.87% 10.30% 11.39% 11.11%
Other Income 0.53 0.15 0.11 0.40 0.49 0.13 0.20 0.25 0.54
Interest 0.15 0.12 0.11 0.11 0.09 0.10 0.17 0.02 0.06
Depreciation 0.77 0.70 0.70 0.72 0.79 0.75 0.75 0.80 0.77
Profit before tax 0.20 0.05 2.71 3.28 2.41 2.28 3.14 4.06 4.46
Tax % 525.00% 0.00% 16.24% 31.10% 55.19% 28.95% 25.48% 32.27% 41.26%
Net Profit -0.85 0.05 2.27 2.26 1.08 1.62 2.33 2.75 2.62
EPS in Rs -0.01 0.00 0.03 0.03 0.01 0.02 0.03 0.04 0.03

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017
115 151 173 184 185
104 135 155 167 168
Operating Profit 11 16 18 17 17
OPM % 9% 11% 11% 9% 9%
Other Income 1 1 1 3 3
Interest 1 0 0 0 0
Depreciation 3 3 3 3 3
Profit before tax 8 14 16 16 16
Tax % 33% 33% 38% 36% 34%
Net Profit 6 9 10 10 11
EPS in Rs 0.07 0.12 0.13 0.13 0.13
Dividend Payout % 24% 17% 16% 15% 15%
Compounded Sales Growth
10 Years:%
5 Years:%
3 Years:7%
TTM:1%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:4%
TTM:1%
Stock Price CAGR
10 Years:28%
5 Years:30%
3 Years:96%
1 Year:332%
Return on Equity
10 Years:%
5 Years:%
3 Years:10%
Last Year:9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017
22 78 78 78 78
Reserves 65 17 22 31 39
Borrowings 2 3 6 6 12
33 42 31 61 50
Total Liabilities 123 140 138 175 180
50 50 46 46 55
CWIP 0 0 0 5 0
Investments 7 9 6 23 36
66 80 85 101 89
Total Assets 123 140 138 175 180

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017
6 7 0 24 14
-0 -4 1 -23 -18
-6 -1 1 -2 5
Net Cash Flow -1 2 2 -1 1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017
ROCE % 15% 16% 15% 13%
Debtor Days 92 71 66 91 91
Inventory Turnover 13.04 11.40 10.17 10.29

Shareholding Pattern

Numbers in percentages

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
38.98 38.98 38.98 38.98 38.98 38.98 38.98 40.14 40.48 40.48 40.48 41.18
0.00 0.00 0.00 0.00 0.00 0.00 0.15 0.01 0.00 0.00 0.00 0.00
61.02 61.02 61.02 61.02 61.02 61.02 60.88 59.85 59.52 59.52 59.52 58.82

Documents